streptococcus vaccine

Pfizer’s Approach to GBS Vaccine Approval Hinges on Immunogenicity Study

Amid the complexities of conducting an efficacy study for a group B streptococcus (GBS) vaccine, Pfizer’s lead vaccine executive is ...